首页 > 市场调查报告书 > 製药

生物製剂分子标靶治疗学

市场调查报告书

商品编码

1547870

全球单株抗体市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Monoclonal Antibodies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球单株抗体市场需求预计将从2023年的2,386.1亿美元达到2032年近6,088.8亿美元的市场规模，2024-2032年研究期间的复合年增长率为10.97%。

单株抗体是相同的免疫球蛋白，由单一 B 细胞克隆产生。它是一种古老的免疫学工具，应用于生物化学、免疫学、生物技术和应用生物学领域。这些是由人体免疫系统对细菌、真菌、寄生虫、病毒、化学物质和其他物质等抗原作出反应而产生的。科学家在实验室中生产抗体来模仿免疫系统的作用，借助免疫疗法来治疗疾病。单株抗体通常透过注射施用。

市场动态

单株抗体的生产是实验室研究的古老做法。其在临床医学领域有广泛的应用。全球实验室的研究揭示了不同科学分支的其他应用。对新疗法的不断探索正在推动市场的成长。人们对抗体产品开发的持续兴趣是由分子层面上疾病的快速发展和理解所驱动的。由于其高度特异性，单株抗体对于理解基础免疫学和分子研究非常有价值。单株抗体越来越多地用于研究和诊断、癌症和免疫疾病的治疗工具以及製药等应用，从而在行业中产生了巨大的需求。目前，单株抗体占白血病、关节炎、乳癌和移植的所有新疗法的三分之一，它们在疾病预测和检测中的作用带来了希望。世界各地的科学家都在寻找 COVID-19 的治疗方法。正在进行的研究表明，单株抗体可以治疗甚至预防 COVID-19，并有望成为市场的下一个重大产品。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球单株抗体市场的各个细分市场进行了包容性评估。单株抗体产业的成长和趋势为本研究提供了整体方法。

市场区隔

单株抗体市场报告的这一部分提供了国家和区域层级细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标群体以及即将到来的机会。

按来源类型

鼠类
嵌合体
人性化
人类

按生产类型

体内
体外

按申请

肿瘤学
自体免疫疾病
传染病
神经系统疾病
其他的

按最终用途

医院
专科中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲单株抗体市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。单株抗体市场的主要参与者包括诺华公司、辉瑞公司、葛兰素史克公司、安进公司、默克公司、第一三共有限公司、雅培实验室、阿斯特捷利康公司、礼来公司、强生服务公司公司。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按来源类型分類的市场吸引力分析
- 按生产类型分類的市场吸引力分析
- 市场吸引力分析：依应用分类
- 按最终用途分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球单株抗体市场分析：依来源类型

按来源类型概述
历史和预测数据
按来源类型分析
鼠类
嵌合体
人性化
人类

第 6 章：全球单株抗体市场分析：依生产类型

按生产类型概述
历史和预测数据
按生产类型分析
体内
体外

第 7 章：全球单株抗体市场分析：依应用分类

概述：按应用
历史和预测数据
分析：按应用
肿瘤学
自体免疫疾病
传染病
神经系统疾病
其他的

第 8 章：全球单株抗体市场分析：依最终用途分类

按最终用途分类的概述
历史和预测数据
按最终用途分析
医院
专科中心
其他的

第 9 章：全球单株抗体市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：单株抗体公司的竞争格局

单株抗体市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Novartis AG

公司概况
公司收入
产品
最新动态

Pfizer Inc

公司概况
公司收入
产品
最新动态

GlaxoSmithKline Plc

公司概况
公司收入
产品
最新动态

Amgen Inc.

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Daiichi Sankyo Company

公司概况
公司收入
产品
最新动态

Limited

公司概况
公司收入
产品
最新动态

Abbott Laboratories

公司概况
公司收入
产品
最新动态

AstraZeneca Plc

公司概况
公司收入
产品
最新动态

Eli Lilly And Company

公司概况
公司收入
产品
最新动态

Johnson & Johnson Services Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11212693

The global demand for Monoclonal Antibodies Market is presumed to reach the market size of nearly USD 608.88 Billion by 2032 from USD 238.61 Billion in 2023 with a CAGR of 10.97% under the study period 2024-2032.

Monoclonal antibodies are identical immunoglobulins, generated from a single B-cell clone. It is an old immunological tool with applications in the fields of biochemistry, immunology, biotechnology, and applied biology. These are produced by the body's immune system in response to antigens such as bacteria, fungi, parasites, viruses, chemicals, and other substances. Scientists produce antibodies in the lab to mimic the action of the immune system to treat diseases with the help of immunotherapy. Monoclonal antibodies are generally administered by injection.

MARKET DYNAMICS

Production of monoclonal antibodies is an old practice in laboratory research. It is widely applied in the field of clinical medicine. Research from the laboratory globally is revealing additional applications in diverse branches of sciences. Growing search for new therapeutics is propelling the growth of the market. The continued interest in antibody product development is driven by the rapid advancement and understanding of disease at a molecular level. MAbs are extremely valuable for understanding basic immunological and molecular research due to their high specificity. MAbs are increasingly used for applications such as research and diagnosis, therapeutic tools in cancer and immunological disorders, and pharmacy, thus generating a great demand in the industry. Currently, MAbs account for one-third of all the new treatments for leukaemia, arthritis, breast cancer, and transplant, their role in disease prediction and detection offers promise. Scientist all over the world is looking for COVID-19 treatment. Ongoing research says that monoclonal antibodies could treat or even prevent COVID-19 and could promise as the next big thing for market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Monoclonal Antibodies. The growth and trends of Monoclonal Antibodies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Monoclonal Antibodies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source Type

Murine
Chimeric
Humanized
Human

By Production Type

In Vivo
In Vitro

By Application

Oncology
Autoimmune Diseases
Infectious Diseases
Neurological Diseases
Others

By End-use

Hospitals
Specialty Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Monoclonal Antibodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Monoclonal Antibodies market include Novartis AG, Pfizer Inc, GlaxoSmithKline Plc, Amgen Inc., Merck & Co. Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories, AstraZeneca Plc, Eli Lilly And Company, Johnson & Johnson Services Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MONOCLONAL ANTIBODIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Source Type
- 3.7.2 Market Attractiveness Analysis By Production Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY SOURCE TYPE

5.1. Overview By Source Type
5.2. Historical and Forecast Data
5.3. Analysis By Source Type
5.4. Murine Historic and Forecast Sales By Regions
5.5. Chimeric Historic and Forecast Sales By Regions
5.6. Humanized Historic and Forecast Sales By Regions
5.7. Human Historic and Forecast Sales By Regions

6. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY PRODUCTION TYPE

6.1. Overview By Production Type
6.2. Historical and Forecast Data
6.3. Analysis By Production Type
6.4. In Vivo Historic and Forecast Sales By Regions
6.5. In Vitro Historic and Forecast Sales By Regions

7. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Oncology Historic and Forecast Sales By Regions
7.5. Autoimmune Diseases Historic and Forecast Sales By Regions
7.6. Infectious Diseases Historic and Forecast Sales By Regions
7.7. Neurological Diseases Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data
8.3. Analysis By End-use
8.4. Hospitals Historic and Forecast Sales By Regions
8.5. Specialty Centers Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE MONOCLONAL ANTIBODIES COMPANIES

10.1. Monoclonal Antibodies Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF MONOCLONAL ANTIBODIES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Novartis AG
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Pfizer Inc
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. GlaxoSmithKline Plc
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Amgen Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Merck & Co. Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Daiichi Sankyo Company
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Limited
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Abbott Laboratories
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. AstraZeneca Plc
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Eli Lilly And Company
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Johnson & Johnson Services Inc
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments